Genetic Cholestasis Syndromes
Clinics in Liver Disease · 2026-08 · 30 (3) · 657-675
DOI: 10.1016/j.cld.2026.04.005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinics in Liver Disease, 2026-08. Verfasst von Eliza Flanagan und 1 weiteren Autor:innen. Beteiligte Einrichtung: The Autoimmune and Rare Liver Disease Programme, University Health Network, Toronto General Hospital, 200 Elizabeth Street, Toronto, Ontario M5G 2C4,…. Hauptthemen laut MEDLINE: Alagille Syndrome, Cholestasis, Intrahepatic. Die Arbeit nennt 68 Literaturangaben.
Abstract (Originalsprache)
This article focuses on common genetic cholestatic liver syndromes, looking at genotype-phenotype correlations in conditions such as progressive familial intrahepatic cholestasis (PFIC), bile acid synthesis disorders and cholangiopathies. It discusses how molecular classification informs prognosis, malignancy risk and therapeutic response. This review also discusses current and emerging therapies, notably ileal bile acid transport inhibitors and their use in PFIC and Alagille syndrome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Autoimmune and Rare Liver Disease Programme, University Health Network, Toronto General Hospital, 200 Elizabeth Street, Toronto, Ontario M5G 2C4, Canada.
- The Autoimmune and Rare Liver Disease Programme, University Health Network, Toronto General Hospital, 200 Elizabeth Street, Toronto, Ontario M5G 2C4, Canada. Electronic address: natassia.tan@uhn.ca.
Zitieren
APA
Flanagan, E., & Tan, N. P. (2026). Genetic Cholestasis Syndromes. Clinics in Liver Disease, 30(3), 657-675. https://doi.org/10.1016/j.cld.2026.04.005
Vancouver
Flanagan E, Tan NP. Genetic Cholestasis Syndromes. Clinics in Liver Disease. 2026;30(3):657-675. doi:10.1016/j.cld.2026.04.005
BibTeX
@article{Flanagan2026,
author = {Flanagan, Eliza and Tan, Natassia Pinpin},
title = {Genetic Cholestasis Syndromes},
journal = {Clinics in Liver Disease},
year = {2026},
volume = {30},
number = {3},
pages = {657--675},
doi = {10.1016/j.cld.2026.04.005}
}
EUVIMED